Experience Counts: Unveiling Patients’ Willingness to Pay for Remote Monitoring and Patient Self-Measurement

This study aimed to (1) estimate patients’ willingness to pay (WTP) for remote monitoring (RM) and patient self-measurement (PSM) for pregnant women at risk of gestational hypertensive disorders, (2) assess the impact of experience with these technologies on WTP, and (3) determine their impact on health-related quality of life (HRQoL). Data collection was part of a multicentric randomized controlled trial, Pregnancy Remote Monitoring II, with 2 interventions: RM and PSM. A contingent valuation survey, combining a payment card and open-ended question, was completed twice by 199 participants. Two-part models analyze the impact of experience on WTP, regression models estimated using ordinary least squares the impact of RM and PSM on HRQoL. The mean WTP amount was approximately €120 for RM and €80 for PSM. Compared with having no experience, WTP RM was €63 higher after a long-term exposure to RM (P = .01) and WTP PSM was €26 lower after a short-term exposure to RM (P = .07). No significant impact of RM or PSM on HRQoL was found. This study contributes to the discussion on the impact of experience on WTP. Those who had a long-term experience with RM, were willing to pay more for RM than those without experience. This confirms our hypothesis that involving patients without experience with the valued treatment, possibly underestimates WTP. A long-term experience has, however, no impact on the WTP for technologies for which the potential benefits are apparent without experiencing them, such as PSM. •Remote monitoring (RM) and patient self-measurement (PSM) are 2 emerging technologies enabling blood pressure monitoring at home. Existing evidence suggests that these new technologies can have a positive impact on the conventional maternal-fetal outcomes (eg, admission and gestational age) in the context of gestational hypertensive disorders (GHDs).•This study determined the willingness to pay (WTP) for RM and PSM for women at risk of GHD, revealing that they had, on average, a higher WTP for RM and PSM than for conventional care. Furthermore, this study assessed the impact of experience with these technologies on the corresponding WTP and found that experience can have a positive impact on WTP for technologies for which imagining the benefits without experiencing them is difficult, such as RM.•This study also assessed the impact of RM and PSM for women at risk of GHD on health-related quality of life and yet found no significant impact.